Next, we examined genetic alterations in the IDO1 gene in HNSCC tumors using cBioPortal, which revealed that IDO1 was altered in 33 out of 504 HNSCC tumor samples (6.5% of the samples, Figure 4A). Here, IDO1 is linked to neoplasm.